series-b
Stage
1
Investors
About
PathogenDx develops and supplies a proprietary D3 Array microarray-based diagnostic platform, along with assays, automation and software, for multiplexed detection and quantitation of bacterial, fungal and viral pathogens. Its solutions target laboratory testing needs in cannabis/agriculture, food safety, and clinical applications.
Explore PathogenDx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.